After cisplatin treatment, the MSCs not only changed the phosphorylation level of many kinases, but also increased the secretion of IL-6 and IL-8, which increased the chemotherapeutic resistance of breast cancer cells to cisplatin [88]. The gene discussed is CXCL8; the disease is breast carcinoma.